Holen Sie sich die Stockscreener-App
5.40
5.68%
0.29
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
90.74%
2.7805
|
1.4578 | 3.1291 | 2.9946 | 2.9393 |
| Depreciation and Amortization |
30.10%
0.0153
|
0.0219 | - | - | - |
| Operating Income/Loss |
90.74%
-2.7805
|
-1.4578 | -3.1291 | -2.9946 | -2.9393 |
| Income/Loss From Continuing Operations Before Tax |
90.18%
-2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
90.18%
-2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
|
Net Income/Loss
|
290.18%
2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
5.5514
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):